Physician profile
Thomas Konia
NPI 1306828033
$3,714.12
in general payments reported to CMS, 2019-2025
18 companies · $457 in 2025
The $457 reported for 2025 was more than what 77% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $125 · 2021: $330 · 2022: $950 · 2023: $709 · 2024: $817 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,983.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,983.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $671.57 | 2019-2025 | |
| Incyte Corporation | $489.24 | 2022-2025 | Opzelura, Opzelura |
| Lilly USA, LLC | $357.15 | 2022-2024 | Olumiant |
| Regeneron Healthcare Solutions, INC. | $245.38 | 2021-2024 | Dupixent |
| Arcutis Biotherapeutics, INC. | $244.62 | 2024 | Zoryve |
| Janssen Scientific Affairs, LLC | $229.67 | 2021-2022 | |
| Pfizer INC. | $216.20 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $206.33 | 2022-2025 | |
| Genentech USA, INC. | $124.56 | 2020 | |
| Dermira, INC. | $124.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.31 | 2023 | Spevigo |
| Dermavant Sciences, INC. | $122.31 | 2023 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $115.88 | 2025 | Cabtreo |
| Leo Pharma INC. | $107.78 | 2022 | |
| Epi Health, LLC | $92.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $86.60 | 2021 | |
| Ucb, INC. | $80.16 | 2024 | Bimzelx |
| Solta Medical, A Division of Bausch Health US, LLC | $77.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Konia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.